GANGLIONIC blockade was first used to produce controlled hypotension during surgery by Scurr (1951) . This technique has since become generally accepted in anaesthetic practice.
Ganglion blocking drugs now available include the methonium compounds and the short acting agents trimetaphan and homatropinium (Trophenium).
There is no doubt that these drugs act selectively on the sympathetic ganglia, which is, perhaps, surprising in view of the similar humoral transmission mechanism thought to operate at other synapses and also at the motor endplates. Biilbring and Depierre (1949) suggested that the differences in the physiological mechanisms at sympathetic ganglia and the neuromuscular junction are quantitative rather than qualitative, and Paton (1954) considers the anatomical differences enough to account for dissimilarities in the actions of drugs at the two sites.
It seems likely that a drug which is active at sympathetic ganglia would, in sufficient concentration, be effective at the motor endplate (and vice versa) .
The methonium compounds have been shown to have a neuromuscular blocking action in very large doses by Barlow and Ing (1948) and by Paton and Zaimis (1948) . These workers showed that as the length of the chain between the quaternary nitrogen atoms decreases, so does the neuromuscular blocking effect diminish, being at its least in the hexane and pentane derivatives. However, large doses of hexamethonium will produce "head-drop" in the rabbit, and this effect is potentiated by curare.
With regard to trimetaphan, Acheson and Pereira (1946) stated that this drug had no curarelike effect. Randall et al. (1949) agreed with this observation and considered a slight muscular 217
weakness noted in dogs to be due to the deficient blood supply caused by the hypotension. It is interesting to note that nearly all the animals which received a lethal dose of trimetaphan died of respiratory failure. Tewfik (1957) , noting a prolongation of suxamethonium apnoea in patients also receiving trimetaphan, suggested that trimetaphan has some slight muscle-paralyzing effect and may be destroyed by pseudocholinesterase. Payne (1957) has recently shown that trimetaphan has a weak neuromuscular blocking effect in cats previously given mecamylamine.
In the case of homatropinium, large doses are reported by Robertson et al. (1957) to produce respiratory paralysis in mice, rats, rabbits and cats. This may indicate the possibility of neuromuscular block occurring with this drug also.
Recent clinical experience has led us to believe that the effect of ganglion blocking drugs on neuromuscular transmission may be of practical importance. Accordingly, we decided to investigate and compare this effect in the case of hexamethonium, trimetaphan and homatropinium.
METHOD
The rat diaphragm preparation (Biilbring, 1946) was selected for this investigation. This provides a preparation of mammalian muscle which can easily be stimulated directly, or indirectly via the phrenic nerve. It may be studied under accurately controllable and reproducible conditions. Because of the large surface area and thin nature of the muscle, it is readily perfused and the effects of changes in the perfusion fluid are rapidly apparent.
Healthy, adult, albino rats were killed by a blow on the head and the diaphragm and phrenic nerves were removed. Each preparation consisted 218 BRITISH JOURNAL OF ANAESTHESIA of that part of the hemidiaphragm which is of costal origin, together with its phrenic nerve. This was perfused in 200 ml of Kreb's solution at 37 °C, through which was bubbled a mixture of 95 per cent oxygen and 5 per cent carbon dioxide. The muscle was secured by its costal origin to an electrode. The insertion into the central tendon was fastened to a fine steel wire serving both as a second electrode and as attachment to a recording lever writing on a smoked drum. The phrenic nerve rested across another pair of electrodes. Both direct muscle stimulation via the first pair of electrodes and indirect (nerve) stimulation via the second pair of electrodes were effected by appropriate supramaximal, squarewave pulses at a frequency of 5 per minute.
In accordance with the object of this investigation, preparations of the drugs involved were those commonly used in anaesthesia.
Each ganglion blocking agent was investigated by three different experiments, as follows.
(1) Effect of ganglion blocking agent alone.
Uniform contractions of the muscle in response both to direct and to indirect stimulation were recorded. Then, during indirect stimulation (i.e. via the phrenic nerve), successive amounts of the drug under investigation were added to the perfusion bath so as to produce a progressive increase in concentration. Finally, direct muscle stimulation was applied in order to determine whether any effect produced by the drug was on the indirect response alone. During this final period of direct stimulation the drug concentration was further increased.
(2) Effect of ganglion blocking agent plus curare.
A fresh preparation was used. Partial curarization was effected before the drug under investigation was added. This same preparation was then thoroughly washed three times with fresh Kreb's solution and allowed to recover fully. Experiment 1 was then performed upon it, in order to establish that any difference in response had been due to the presence of curare and not to any peculiarity of the preparation.
(3) Effect of Neostigmine on recovery from ganglion blocking agent. A preparation was exposed to a concentration of ganglion blocking drug sufficient to produce maximal response. It was then perfused in a lower concentration so that relatively slow recovery occurred. During this recovery phase indirect stimulation was applied and neostigmine was then added.
RESULTS
In untreated preparations it was found that uniform contractions resulted from both direct and indirect stimulation. Response to the former was greater than the response to the latter. This is usual with this preparation and the accepted explanation is as follows. Direct stimulation causes each muscle fibre to contract. The associated action potential traverses the fibre and excites the nerve fibrils of the motor endplate as it passes. A secondary response is produced and summation results in an increased contraction. Neuromuscular block will prevent this secondary effect from influencing the muscle fibre, and the observed twitch following direct stimulation is then comparable to that caused by indirect stimulation of an untreated (noncurarized) preparation.
All the drugs investigated modified the response of the preparation. The effects produced were as follows.
Hexamethonium bromide ( fig. 1 ). 200 mg of this drug produced no effect. A further 100 mg produced a diminution of the twitch and a final 100 mg resulted in complete neuromuscular block. Direct stimulation still produced active contractions (reduced slightly to the level of the original indirect response, as explained above) and these were unaffected by two further 200 mg doses of hexamethonium.
Hexamethonium produced neither initial potentiation of the contractions nor spontaneous muscle twitches.
Hexamethonium plus curare ( fig. 2 ). Two 0.1 mg doses of d-tubocurarine produced partial neuromuscular block. Following this, only 250 mg of hexamethonium (in divided doses) produced total block. It is interesting to note the initial anatagonism to curare produced by the first 100 mg dose of hexamethonium. After washing, this same preparation required a total of 375 mg of hexamethonium before total block was produced ( fig. 3) .
Hexamethonium plus neostigmine ( fig. 10a) . Neostigmine 1 mg assisted the recovery from neuromuscular block produced by hexamethonium.
Trimetaphan (fig. 4) . Two 20 mg doses produced no effect, but a third similar dose produced total neuromuscular block. As before, the direct response was also slightly reduced, but further doses of 20 mg and 40 mg had no effect on it. No initial stimulation or muscle fasciculation was seen with trimetaphan.
Trimetaphan plus curare ( fig. 5) . Following partial curarization, only 20 mg of trimetaphan produced total block. After washing, this same preparation required 60 mg of trimetaphan (in divided doses) before complete block occurred ( fig. 6) .
Trimetaphan plus neostigmine ( fig. 10b ). Neostigmine 1 mg increased the degree of neuro- Homatropinium ( fig. 7) . 20 mg had no effect. A further 20 mg produced total neuromuscular block. Again the direct response was slightly depressed, but was unaffected by a further 20 mg and 40 mg of homatropinium. No initial stimulation or muscle fasciculation occurred.
Homatropinium plus curare ( fig. 8) . Following partial curarization, only 20 mg of homatropinium produced total block. After washing, this same preparation required 40 mg of homatropinium to effect total block ( fig. 9) .
Homatropinium plus neostigmine ( fig. 10c ). Neostigmine 1 mg accelerated the recovery from total homatropinium block.
The above results are summarized in table I. In order to establish the effect of neostigmine alone, 1 mg was added to a fresh preparation. This produced an increase in the amplitude of the contractions, as shown in figure lOd.
DISCUSSION
All three ganglion blocking drugs examined were found capable of neuromuscular blockade. This has not previously been reported in the case of trimetaphan or homatropinium.
In no case was any initial muscle stimulation or fasciculation seen. This probably indicates that the neuromuscular blocking mechanisms are not of the depolarizing type. This is supported by the improvement in contractions that followed the addition of neostigmine to preparations recovering from total hexamethonium and homatropinium block. The neuromuscular blocking effect rat diaphragm preparation. N = Indirect stimulation (via phrenic nerve), doses in mg.
(c) Preparation recovering from complete neuromuscular block produced by homatropinium. Improvement in contractions following neostigmine 1 mg.
(d) Improvement in contractions following the addition of neostigmine 1 mg to preparation unaffected by other drugs.
of hexamethonium, reported by Paton and Zaimis (1952) , is recognized to be of nondepolarizing type. In the case of trimetaphan, however, the recovery from total block was halted, and, in fact, the block made more profound by the addition of neostigmine. Tewfik (1957) has shown experimentally that, in vitro, trimetaphan suppresses cholinesterase. It may be that this is the mechanism whereby trimetaphan upsets neuromuscular transmission, and this would explain the potentiation produced by neostigmine, which, of course, also has powerful anticholinesterase activity.
To assess their clinical significance, these results must be considered quantitatively.
In the case of hexamethonium, the huge total of 400 mg was required to produce neuromuscular block, in a perfusion bath of 200 ml capacity.
Even after partial curarization, 250 mg was required. It is unusual for more than 300 mg of hexamethonium bromide to be used in anaesthetic practice, and we consider, therefore, that, normally, the curare-like effect of this drug can be ignored. However, Payne (1957) has recommended caution in the administration of hexamethonium to patients receiving mecamylamine, as he considers that this combination might produce neuromuscular block.
Trimetaphan produced paralysis of the preparation after a total of 60 mg (30 mg per cent) had been given, but only 20 mg (10 mg per cent) was required after partial curarization. The clinical requirements of trimetaphan vary considerably. Large amounts may be needed in resistant patients, where tachyphylaxis occurs, when the position of the patient does not favour the production of hypotension, or if coarctation of the aorta exists. Vermeulen-Cranch (1956) records the use of 2,400 mg and doses of this order are not uncommon. In such cases we believe neuromuscular transmission may be depressed.
The fate of trimetaphan in the body is not known, but the transient hypotensive effect of a single dose suggests a rapid breakdown. Gertner et al. (1955) recovered, unchanged, from the urine only one third of the amount administered. If the remainder is, as Tewfik (1957) suggests, destroyed in vivo by pseudocholinesterase, then patients having a low pseudocholinesterase level would be more likely to show neuromuscular effects, particularly if relaxants or neostigmine are also given.
Homatropinium produced complete block in lower dosage than trimetaphan. After partial curarization only 20 mg (10 mg per cent) was required. In clinical use, Robertson (1957) reports the administration of 2,280 mg to one patient. It appears, therefore, that the neuromuscular blocking action of homatropinium may be of practical significance. A point in favour of this drug, as compared with trimetaphan, is that this curare-like effect is antagonized by neostigmine.
SUMMARY
Experiments to investigate the actions of hexamethonium, trimetaphan and homatropinium on neuromuscular transmission are described.
All three drugs are shown to produce neuromuscular block. Preliminary curarization reduces the dose required. Neostigmine antagonizes this action of hexamethonium and homatropinium, but potentiation occurs in the case of trimetaphan.
These results and their possible clinical implications are discussed.
